Sort by
Refine Your Search
-
nanoparticles to join our vaccine stabilization team, jointly at the School of Pharmacy and School of Biochemistry and Cell Biology, in University College Cork. The scientist will work within a Horizon-Europe
-
to assess the clinical applicability of cyclin-dependent kinase inhibitors (CKIs) as a novel treatment option for GBM patients. By combining, 3D cultures, cancer stem cell populations, large scale high
-
” platform. The research focuses on uncovering the biomolecular pathways that control cell behaviour under these conditions, combining protein and RNA biochemistry, biochemical and functional assays, and
-
automated droplet-based microfluidic platform for functional T-cell analysis. We’re seeking a talented researcher or engineer to design, fabricate, and test microfluidic devices that integrate precision
-
; Rehill et al., Science Advances 2025). This Research Ireland-funded project will elucidate how components of the coagulation cascade modulate inflammatory cell signalling, with a view to developing novel
-
available treatment. In a secondary objective aimed at providing mechanistic understanding, the candidate will identify drug-drug interactions and study the cellular mechanisms at play in induced pluripotent
-
mechanistic understanding, the candidate will identify drug-drug interactions and study the cellular mechanisms at play in induced pluripotent stem cells (iPSCs) and kidney organoids. These preclinical studies
-
in this regard. The candidate will perform faecal microbial transplantation and behavioural analyses in rodents, immunohistochemistry and microscopy with cellular morphological analysis, gene and
-
cellular morphological analysis, gene and protein expression analyses, 16S rRNA gene sequencing, metabolomics and statistical analysis, and apply for ethical approval for the research. UCC is an accredited